Dougherty & Co Maintains a 'Buy' on Vascular Solutions (VASC); Q2 Preview
Tweet
Share
E-mailGet Alerts VASC Hot Sheet
Price: $56.00 --0%
Rating Summary:
0 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Dougherty & Co maintains a 'Buy' on Vascular Solutions (NASDAQ: VASC) price target of $15.50 (from $12.50).
Analyst, Deepak Chaulagai, said, "VASC will report Q2 FY12 results on July 24th after the close. We are modeling Q2 at $24.3M revenue (+9.1% Y/Y)/$0.13 GAAP EPS (+5.6% Y/Y), in-line with consensus estimates and within the range of management’s guidance ($24.1M to $24.5M revenue; $0.13 to $0.15 EPS)."
For an analyst ratings summary and ratings history on Vascular Solutions click here. For more ratings news on Vascular Solutions click here.
Shares of Vascular Solutions closed at $12.99 yesterday.
Analyst, Deepak Chaulagai, said, "VASC will report Q2 FY12 results on July 24th after the close. We are modeling Q2 at $24.3M revenue (+9.1% Y/Y)/$0.13 GAAP EPS (+5.6% Y/Y), in-line with consensus estimates and within the range of management’s guidance ($24.1M to $24.5M revenue; $0.13 to $0.15 EPS)."
For an analyst ratings summary and ratings history on Vascular Solutions click here. For more ratings news on Vascular Solutions click here.
Shares of Vascular Solutions closed at $12.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- DA Davidson Reiterates Neutral Rating on Timken (TKR)
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
